Create a Report
Please provide report title
Please provide location
Please provide details
Get alerts and updates for your case! Your contact information is not shown on the website.
This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.
Please accept our Terms & Conditions

We do not show your email or contact info

Please provide email or phone
Please provide email or phone
Add photos or video
We recommend photos and videos to help explain your report
Add Photo/Video
Email or SMS copy of report
Enter below to get emailed a copy of your report, or sms a link to your report
Please provide email or phone
Please provide email or phone
Please accept our Terms & Conditions
Thank you for your report!
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Goodbye! and best wishes in your recovery
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Report by
Loading...
Please provide location
Please provide location
Please provide report title
Please provide details
Please accept our Terms & Conditions
Get alerts and updates for your case! Your contact information is not shown on the website.

This information is not shown on the website. We can notify you of updates, and may contact you for more information to help resolve or follow up on your issue.

or
Please provide email or phone
Thank you for your report!

IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)

Visit our learn pages for more helpful information or, email us: support@safelyhq.com

Goodbye! and best wishes in your recovery

Pfizer Covid-19 Vaccine - First Dose, Loudon, NH, USA

3 years ago

Loudon, New Hampshire, United States

The vaccine spot was in Laconia, We went the earliest morning slot I could (3-15-21) and it wasn't busy at all since they don't have a drive thru option. The process was easy and simple. Getting the shot, I didn't feel needle going in or feel the coldness of the shot like I do with flu shots. A few seconds after injected, I felt my arm stiff but not sore or in pain. I took Tylenol as soon as I got back into the car. Around 30 mins later I felt my arm feel a burn like sting sensation and it went away within an hour. I took a muscle relaxer as well when I got home and within few hours I fell asleep. Woke back up 3 hours later and my arm was a little sore. (Flu shots make my arm feel like someone punched it and lasts for whole day and Pfizer didn't feel anything close to that) Pfizer first dose was pretty mild. My mom who is 59 years old, got the Pfizer shot with me at the same time, and her symptoms were different than mine. When she got it and after injected she didn't feel anything. About 15 mins later she feels her arm stiff and sore. She also took Tylenol as soon as she got into the car. She got home and few hours goes by she falls asleep, her arm is hurting her more. On (3-16-21) she was really tired just couldn't stay awake and her arm was still really sore. On (3-17-21) She was still sleepy and she couldn't move her arm at times where she was still sore. On (3-18-21) her arm was still sore but not as sore as it was for those last couple of days, it was pretty mild and wasn't so tired anymore. On (3-19-21) She feels 100% better today. | Symptoms: Other, Soreness

5


Related Reports

I got this covid booster, and flu shot at the same time. Zero side effects so far, and I am on day 3 now. I assume by now I am in the clear. The picture says moderna, but he assured me it was the pfizer. See Less
544


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion (containing benzyl alcohol), 100mL Single Patient Use Glass Fliptop Vial; lot EA7470, to the user level due to visible particulates observed in two vials during annual examination of retention samples. The product lot... See More was distributed nationwide to wholesalers/hospitals in the United States from July 16, 2020 through July 24, 2020. To date, Pfizer has not received reports of any adverse events associated with this issue for this lot.

Risk Statement: Patients receiving the impacted product have a remote probability of experiencing potential adverse events, such as blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a Single Patient Use Glass Fliptop Vial. The NDC, Lot Number, Expiration Date, and Configuration details for Propofol Injectable Emulsion are indicated below.

Product: Configuration/Count Propofol Injectable Emulsion, 100 mL Single Patient Use Glass Fliptop Vial
NDC: Vial: 0409-4699-54 Tray: 0409-4699-24
Lot Number: EA7470
Expiration Date: 01 JUNE 2023
Presentation: 1g/100 mL, Single Patient Use Glass Fliptop Vial
Configuration/Count: Tray of 10 Units

Pfizer places the utmost emphasis on patient safety and product quality at every step in the manufacturing and supply chain process. Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should discontinue use, stop distribution and quarantine immediately. If you have further distributed the recalled product, please notify your accounts and/or any additional locations which may have received the recalled product. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira, Inc., a Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: August 22, 2022

Source: fda.gov
See Less
303


Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), 100 mL Single Patient Use Glass Fliptop Vial; lot DX9067, to the user level due to a visible particulate observed in a single vial during annual examination of retain... See More samples. The product lot was distributed nationwide to wholesalers/ hospitals/Department of Defense in the United States from June 10, 2020 through June 26, 2020.

The recalled product is:
- Propofol Injectable Emulsion, USP 100 mL Single Patient Use Glass Fliptop Vial, NDC: Vial: 0409-4699-54 Carton: 0409-4699-24, Lot Number: DX9067, Expiration Date Presentation: 01 MAY 2023, Configuration/Count: 1 g/100 mL, Single Patient Use Glass Fliptop Vial Case of 10 Units.

Risk Statement: Patients receiving the impacted product are at risk of experiencing life-threatening adverse clinical effects including but not limited to: blockage of blood vessels, including decreased blood flow to the brain, heart attack, pulmonary embolus, and tissue necrosis. Hypersensitivity reactions and transmission of infectious disease can also occur.

To date, Hospira, Inc. has not received reports of any adverse events associated with this issue for this lot. Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Propofol Injectable Emulsion, USP is a terminally sterilized (TS) product. It is a sterile, nonpyrogenic emulsion containing 10 mg/mL of propofol suitable for intravenous administration supplied in a single patient use fliptop vial.

Wholesalers or hospitals with an existing inventory of the lot, which is being recalled, should stop use and distribution and quarantine immediately. If you have further distributed the recalled product, to the wholesale or hospital level/institution, please notify any accounts or additional locations which may have received the recalled product from you. Hospitals/Institutions should inform Healthcare Professionals in your organization of this recall.

Company name: Hospira Inc, A Pfizer Company
Brand name: Hospira
Product recalled: Propofol Injection Emulsion, USP
Reason of the recall: Potential presence of visible particulate
FDA Recall date: July 13, 2022

Source: fda.gov
See Less
303


Pfizer is voluntarily recalling Accuretic (quinapril HCl/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril and hydrochlorothiazide and quinapril HCl/ hydrochlorothiazide) to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake (ADI) level.... See More To date, Pfizer is not aware of reports of adverse events that have been assessed to be related to this recall. 

Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets and four lots of quinapril HCl/ hydrochlorothiazide tablets. Nitrosamines are common in water and foods, including cured and grilled meats, dairy products and vegetables. Everyone is exposed to some level of nitrosamines. These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.

These products are indicated for the treatment of hypertension.  Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. The products have a safety profile that has been established over 20 years of marketing authorization and through a robust clinical program. Pfizer believes the benefit/risk profile of the products remains positive based on currently available data. Although long term ingestion of N-nitroso-quinapril may be associated with a potential increased cancer risk in humans, there is no immediate risk to patients taking this medication. Patients currently taking the products should consult with their doctor about alternative treatment options.

The NDC, Lot Number, Expiration Date, and Configuration details for these products are indicated in the tables in the link below and photos of the products can be found below. The product lots were distributed nationwide to wholesalers and distributors in the United States and Puerto Rico from November 2019 to March 2022.

- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
- Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg
- quinapril and hydrochlorothiazide tablets, 20/25 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
- quinapril HCl/hydrochlorothiazide tablets, 20/25 mg

Pfizer has notified direct consignees by letter to arrange for return of any recalled product.

Wholesalers and distributors with an existing inventory of the lots, listed in the table above, should stop use and distribution and quarantine the product immediately.

If you have further distributed the recalled product, please notify any accounts or additional locations which may have received the recalled product from you.

Company name: Pfizer
Brand name: Accuretic, Greenstone Brand
Product recalled: Accuretic™ (quinapril HCl/hydrochlorothiazide); quinapril and hydrochlorothiazide; and quinapril HCl/hydrochlorothiazide tablets
Reason of the recall: Presence of a nitrosamine, N-nitroso-quinapril
FDA Recall date: March 22, 2022

Source: fda.gov
See Less
303


On Thursday 29th, outages were being reported by Eversource, the state’s largest utility, as well as Unitil and the New Hampshire Electric Co-Op. Eversource reported more than 10,000 customers without power, including significant outages in Barnstead, Loudon, Hooksett, and New Boston, as well as smaller outages in... See More Rye, Nashua, Hollis, Milford, North Hampton, Concord, Weare, Brookline, Dunbarton, Amherst, and Portsmouth. The company does not report restoration times. At just after 12:30 a.m., more than 1,600 Concord and Epsom residents lost power. More minor outages, about 350, were reported in Unitil communities on the Seacoast, including Atkinson, Hampton, Hampton Falls, Kensington, and Kingston, were reported by the company.

Unitil: outage-map.unitil.com
Eversource: outagemap.eversource.com

Source: patch.com
Published: 2024-02-28
See Less
5


I received a 'cool towel' in the mail - I DID NOT ORDER!! In fact, I wasn't even sure what it was.
The return label:
Diane Williams
1794 E 46TH St
Los Angeles, CA 90058


I live in Tennessee! See Less
38


Thousands of power outages were reported across East Tennessee Thursday amid severe thunderstorms. As of 2:25 p.m., the Knoxville Utilities Board reported that 7,351 people were without power. The Lenoir City Utilities Board reported that 1,814 customers were without power in its service area, which included parts... See More of Knoxville, Lenoir City, Oak Ridge and Loudon.

Outage link: lcub.com
Source: wvlt.tv
Published: 2023-01-12
See Less
38


There were more than 70,000 customers without power across the Bay State as of 8:40 a.m., according to the Massachusetts Emergency Management Agency, though that number dropped below 50,000 around noon. Power outages were widespread across New England as well. In Connecticut, nearly 100,000 people had lost... See More power. In New Hampshire, at least 64,000 customers were in the dark as of 8:45 a.m.

Eversource outage map: outagemap.eversource.com
National Grid: outagemap.ma.nationalgridus.com

Source: nbcboston.com
Published: 2022-12-23
See Less
5


Recent Interesting Reports

I ordered two beach chairs on January 9 and I have not received them nor do I have a tracking number or any email confirmation. See Less


Multiple UPS packages received from "Katie Sanchez", from multiple eastern US address. Three or four to date, all small, flat packages containing claning wipes or other small, flat wipes, along with cardboard insert for stiffness. One package contained nothing but the cardboard. These packages are addressed to... See More my address, and to persons that have never lived here-and I have not validated their actual existence, be it anywhere else. Just seems odd. See Less
483


I received a package today, March 25, 2024 that I did not order. The package contains 2 bars of orange soap. There's no lable or anything attached. I looked up the address from where it was shipped from in California. It's a warehouse called Cambria that is... See More no longer in operation. The building is up for sale. See Less
233


Pkg came by USPS  did not order. Has Hazmat service transportation surface only.  Return to Jerry (001) Yasfbara 9208 Charles Smith Ave,Rancho Cucamonga ca91730.
I am returning. USPS tracking#9261292700545500070020****

Im in Fair Oaks, CA, USA See Less
702


Amneal Pharmaceuticals, LLC. Bridgewater, New Jersey (Amneal), is voluntarily recalling 4 lots (see table below) of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL packaged in 80 mL, 150 mL, or 300 mL pack sizes, to the Consumer Level. Some bottles may have been overfilled which can... See More result in an over-potent dosing regimen. The affected Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL lots were distributed Nationwide in the USA directly to Wholesalers and Distributors. The Lots were distributed between 11/09/2023 and 2/20/2024. To date, Amneal has not received any reports of adverse events that have been confirmed to be directly related to this recall.

Risk Statement: Adult patients who are prescribed the maximum daily dose of up to 2 grams per day of Vancomycin Hydrochloride for oral solution, USP 250 mg/5mL, may receive up to 4 grams of oral vancomycin per day because of the overfilled bottle. Some patients with inflammatory disorders of the intestinal mucosa also may have significant systemic absorption of vancomycin. These patients may be at risk for the development of adverse reactions associated with higher doses of vancomycin oral solution. Worsening renal function could be associated with electrolyte abnormalities such as high potassium leading to cardiac arrest.

The recommended maximum daily dose allowance for this product is up to 2gm/day and patients prescribed a dosing regimen of 500 mg/10mL would exceed this daily allowance, which may be harmful to patients with renal insufficiency. The error occurred during the manual bottle filling stage of manufacturing.

Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL, is administered orally for treatment of enterocolitis caused by Staphylococcus aureus (including methicillin-resistant strains) and antibiotic- associated pseudomembranous colitis caused by C. difficile.

The Vancomycin HCl for Oral Solution, USP, 250 mg/5mL subject to the recall, are identified by the NDC numbers stated on the product label. The following lot numbers of Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL are included in this recall.

Vancomycin Hydrochloride for Oral Solution, USP, 250mg/5mL.
- Pack Size: 80 mL, Expiration Date: 09/2025, Lot: 22613003A, NDC No.: 69238-2261-3.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613004A, NDC No.: 69238-2261-7.
- Pack Size: 150 mL, Expiration Date: 09/2025, Lot: 22613005A, NDC No.: 69238-2261-7.
- Pack Size: 300 mL, Expiration Date: 09/2025, Lot: 22613005B, NDC No.: 69238-2261-5.

Anyone with an existing inventory of the product being recalled should examine the product and quarantine any of the recalled lots immediately. Retailers who have Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL, which are being recalled, should examine their inventory and cease dispensing any of the impacted lots.

In case you experience harm from this product, it is important to report it. It can help to detect & resolve issues and prevent others from being harmed, and it enables better surveillance. If symptoms persist, seek medical care.

Company name: Amneal Pharmaceuticals, LLC.
Brand name: Amneal
Product recalled: Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL
Reason of the recall: Super potent due to bottles being overfilled
FDA Recall date: March 27, 2024

Source: fda.gov
See Less


Same story, but I don’t think I ordered anything like the jeans talked about here. I have no idea where it came from 😡 See Less
8


Like many other people… 2 containers of product arrived each in its own bubble envelope… return address fulfillment house P.O. Box 5708 Tampa Fl…. Mailed to me 3-7-24 … phone number on container 800-609-4174…. Called it and no one speaks English

Myrtle Beach, SC See Less
522


Last 30 days